⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Les réformes réglementaires de l’UE et l’innovation mondiale dans le domaine des soins de santé seront au cœur de la conférence DIA Europe 2026
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Regulatorische Reformen der EU und globale Innovationen im Gesundheitswesen stehen auf DIA Europe 2026 im Mittelpunkt
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Regulatorische Reformen der EU und globale Innovationen im Gesundheitswesen stehen auf DIA Europe 2026 im Mittelpunkt
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036
globenewswire.com
SNY
REGN
AMGN
AZN
GSK
NVS
TEVA
EU Regulatory Reforms and Global Healthcare Innovation to be Focus of DIA Europe 2026
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0
globenewswire.com
PFE
MRNA
NVS
MRK
SNY
AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0
globenewswire.com
PFE
MRNA
NVS
MRK
SNY
Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
globenewswire.com
JNJ
BMY
SNY
PFE
BAX
NVS
GSK
SUN
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
globenewswire.com
SNY
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
globenewswire.com
SNY